Context Therapeutics is trading at $0.23, up 12.82% in pre-market on November 3; no clear company-specific announcement explaining the move was identified.
- The provided previous close was $0.20; supplied price context also shows a 6.82% gain at the November 2 close.
- A Q3 2026 earnings preview is circulating, and Nasdaq lists an estimated November 4 earnings date. The upcoming report does not establish the reason for the move.